Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Characterization and Clinical Management of Dilated Cardiomyopathy
| Characterization and Clinical Management of Dilated Cardiomyopathy |
| Autore | Merlo Marco |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (232 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
alternative splicing
arrhythmias arrhythmic risk stratification atrial fibrillation biomarkers calcium cardiac channelopathy cardiac magnetic resonance cardiac magnetic resonance imaging cardiac resynchronization therapy cardiac sodium channel cardiomyopathy congenital heart disease congestive heart failure desmin diastolic dysfunction dilated cardiomyopathy DNA methylation duchenne muscular distrophy epigenetics gene therapy genetics heart heart failure laminopathy late gadolinium enhancement left atrial strain left ventricle non-compaction cardiomyopathy left ventricle sphericity index left ventricular noncompaction left ventricular reverse remodelling LMNA long axis strain long-term outcomes major adverse cardiovascular events malignant ventricular arrhythmia mammalian target of rapamycin (mTOR) complex-1 mdx membrane stabilization mitochondrial dysfunction muscular dystrophy myopathy n/a non-ischemic cardiomyopathy non-sense mRNA decay nonischemic dilated cardiomyopathy NT-proBNP oxidative stress phospholamban phosphorylation precision medicine RNA binding motif protein 20 (RBM20) sarcomere SCN5A Serca2a sex differences supraventricular arrhythmia systolic dysfunction tachycardiomyopathy titin troponin T ventricular arrhythmia whole exome sequencing |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557595503321 |
Merlo Marco
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Novel Biomarkers for Heart Disease
| Novel Biomarkers for Heart Disease |
| Autore | Lichtenauer Michael |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (420 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
acute kidney injury
acute myocardial infarction AMI aneurysm aortic disease aortic regurgitation atrial fibrillation atrial myopathy biomarker biomarkers carbohydrate antigen-125 cardiac biomarkers cardiac intensive care units cardiac magnetic resonance imaging cardiometabolic disease cardiometabolic risks cardiovascular death cardiovascular diseases cardiovascular events cardiovascular risk cardiovascular surgery catestatin cell adhesion molecule ceramides ceruloplasmin chronic heart failure chronic kidney disease circulating cells circulating miRNAs CKD cohort studies coronary artery disease CVD diet quality echocardiography ejection fraction epicardial adipose tissue epicardial fat epicardial fat volume FABP3 fatty acid-binding protein 3 Framingham risk score GDF-15 GDF8 growth differentiation factor 15 (GDF-15) H-FABP healthy eating index heart failure heart failure decompensation heart-type fatty acid-binding protein heart-type fatty acid-binding protein (H-FABP) herat failure HF HFpEF HFrEF hypertension inflammatory marker KLF4 left ventricular adverse remodelling left ventricular ejection fraction left ventricular systolic function liver-type fatty-acid-binding protein long-term outcomes longitudinal strain magnetic resonance imaging magnetic resonance spectroscopy metabolic syndrome microRNA miRNA mitochondrial DNA (mtDNA) mitochondrial dysfunction muscle wasting myocardial infarction myocardial triglyceride content myostatin n/a NAFLD NAFLD fibrosis score NT-proBNP NYHA functional class obesity older women operative risk oxidative stress PBMCS Pentraxin-3 platelets PPCI pregnancy-associated plasma protein-A primary prevention reactive oxygen species (ROS) renal dysfunction repeated measurements risk prediction risk stratification saliva salivary biomarkers sarcopenia secondary prevention SOCE soluble suppression of tumorigenicity 2 (sST2) soluble urokinase-type plasminogen activator receptor (suPAR) sST2 STEMI STIM1 sudden cardiac death suPAR synthetic phenotype T1 mapping TGF-β pathway thyroid-stimulating hormone troponin vena contracta area ventricular arrhythmia ventricular tachycardia very low-density lipoprotein |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557546203321 |
|
Lichtenauer Michael
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Sudden arrhythmic death : from basic science to clinical practice / / topic editors, Ian N. Sabir, Christopher L.-H. Huang and Gareth D. Matthews
| Sudden arrhythmic death : from basic science to clinical practice / / topic editors, Ian N. Sabir, Christopher L.-H. Huang and Gareth D. Matthews |
| Autore | Ian N. Sabir |
| Pubbl/distr/stampa | Frontiers Media SA, 2014 |
| Descrizione fisica | 1 online resource (136 pages) : illustrations; digital file(s) |
| Collana | Frontiers Research Topics |
| Soggetto topico |
Sudden death
Sudden death - Prevention Cardiac arrest - Pathophysiology |
| Soggetto non controllato |
ventricular arrhythmia
Inherited arrhythmia syndromes sudden death arrhythmia mechanisms Channelopathies ventricular tachycardia cardiac modelling Ventricular Fibrillation Atrial Fibrillation Brugada Syndrome |
| ISBN | 9782889192694 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910137224603321 |
|
Ian N. Sabir
|
||
| Frontiers Media SA, 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||